Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis

Journal of Dermatology

Volumn 40, Issue 9, 2013, Pages 736-739

  Yano, Chizuko ^a   Saeki, Hidehisa ^a   Ishiji, Takaoki ^a   Ishiuji, Yozo ^a   Sato, Junko ^a   Tofuku, Yukari ^a   Nakagawa, Hidemi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

atopic dermatitis; dermatology life quality index; Japanese; severity scoring of atopic dermatitis; work productivity and activity impairment

Indexed keywords

ANTIHISTAMINIC AGENT;

ADULT; ARTICLE; ATOPIC DERMATITIS; DERMATOLOGY LIFE QUALITY INDEX; DISABILITY; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE;

ATOPIC DERMATITIS; DERMATOLOGY LIFE QUALITY INDEX; JAPANESE; SEVERITY SCORING OF ATOPIC DERMATITIS; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT;

ADULT; DERMATITIS, ATOPIC; EFFICIENCY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; WORK; YOUNG ADULT;

EID: 84883554574     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12220     Document Type: Article

References (13)

1. Saeki H, Furue M, Furukawa F, et al,. Guideline for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
2. Reilly MC, Zbrozek AS, Dukes EM,. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconimics 1993; 4: 353-365.
3. Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B,. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005; 136: 148-154.
4. Fairchild CJ, Meltzer EO, Roland PS, Wells D, Drake M, Wall GM,. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis. Allergy Asthma Proc 2007; 28: 716-723.
5. Thompson AK, Finn AF, Schoenwetter WF,. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000; 43: 24-30.
6. Fowler JF, Ghosh A, Sung J, et al,. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol 2006; 54: 448-457.
7. Wu Y, Mills D, Bala M,. Impact of psoriasis on patients' work and productivity. Am J Clin Dermatol 2009; 10: 407-410.
8. Murota H, Kitaba S, Tani M, Wataya-Kaneda M, Katayama I,. Effects of nonsedative antihistamines on productivity of patients with pruritic skin diseases. Allergy 2010; 65: 929-930.
9. Murota H, Kitaba S, Tani M, et al,. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010; 59: 345-354.
10. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
11. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
12. Kimball AB, Yu AP, Signorovitch J, et al,. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 66: e67-e76.
13. Hayashi T, Saeki T, Ito T, et al,. Impact of disease severity on work productivity and activity impairment in Japanese patients with psoriasis. J Dermatol Sci (in press).